The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prediction of venous thromboembolism in ambulatory patients with cancer receiving chemotherapy: An expanded thromboembolic risk score model.
R. Labianca
No relevant relationships to disclose
G. Gasparini
No relevant relationships to disclose
S. Barni
No relevant relationships to disclose
M. Verso
No relevant relationships to disclose
E. Bonizzoni
No relevant relationships to disclose
M. Brighenti
No relevant relationships to disclose
M. Mandala
No relevant relationships to disclose
F. Petrelli
No relevant relationships to disclose
C. Bianchini
Employment or Leadership Position - Italfarmaco
T. Perrone
Employment or Leadership Position - Italfarmaco
G. Agnelli
Honoraria - Bayer; Boehringer Ingelheim; Sanofi